Deutsche Bank
SCPS

Deutsche Bank’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Deutsche Bank’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,495
Closed -$30K – 4915
2021
Q1 		$30K Buy
+3,495
New +$36.6K ﹤0.01% 4342

Other funds holding SCPS

BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's SCPS Position: Q2 2021 in Review

Deutsche Bank sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q2 2021, closing a stake of 3,495 shares — an estimated $30K sold.

Deutsche Bank first reported a position in SCPS in Q1 2021 and held it in 1 quarter. The position peaked at $30K in Q1 2021. 15 funds tracked by Wall St. Rank hold SCPS as of Q2 2021.

  • Deutsche Bank reported no remaining Scopus BioPharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 3,495 Scopus BioPharma Inc. Common Stock shares in Q2 2021, an estimated $30K.
  • Deutsche Bank first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Deutsche Bank's Scopus BioPharma Inc. Common Stock position peaked at $30K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.